Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

NCT01865201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Brain Necrosis

Interventions

DRUG: Edaravone
OTHER: Common fundamental management

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University